Trial
NCT03749447
An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Biogen
Collaborators
—
Condition
Chronic Kidney Diseases
Intervention
Bardoxolone methyl
Why stopped
Discontinuation of all bardoxolone chronic kidney disease programs
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-03